Tag: Lysis

Investment firm Jefferies maintains its Buy rating on Vestis Corp, highlighting its well-executed turnaround strategy and potential for margin improvement ...

Deutsche Bank downgrades Masonite International's stock rating and increases price target, citing promising benefits from the recent agreement with Owens ...

JPMorgan gives an optimistic outlook for Palmer Square Capital BDC, assigning it an Overweight rating and $17.00 price target. The ...

The weekly chart analysis shows a critical juncture for the market, with potential upheaval and a strong bull channel. The ...

Tango Therapeutics receives positive coverage from Piper Sandler, emphasizing its strong position in precision oncology. The firm believes the company's ...

Financial firm Bernstein believes that Lyft's upcoming fourth quarter update will be key to its future success. The report suggests ...

AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...

Analysts predict AI-integrated iPhones could boost Apple's stock and sales, potentially leading to more device replacements and revenue opportunities.

Renowned analyst Eric Krown predicts Ethereum's rally will continue towards the low $3000s, highlighting its strength, bullish technical indicators, and ...

Roku's fourth-quarter results are anticipated to surpass estimates, according to Evercore ISI. However, the firm cautions that high investor expectations ...